Frontlight ResearchEarly access
Trial site
MVZ Ⅱ der Niels Stensen Kliniken
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 32 trials
- Status
- Active, not recruiting3 trials
- Lead sponsor
- Dizal Pharmaceuticals1 trial
- GBG Forschungs GmbH1 trial
- Pfizer1 trial
Running trials
Active, not recruiting
Active, not recruiting
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
Active, not recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026